It’s not all that surprising when surveying the high end market. There are going to be some patients who are hit financially who space out treatments and net net some decrease in use probably but you’re right Botox withstands economic turbulence surprisingly well. The need to distance hopefully won’t be too much of an issue on the supply side. Docs will have to start earlier and end later.
Market Data 
Markets 
AI
